Here are four things to know.
1. Takeda focuses on oncology, gastroenterology and neuroscience. The company also develops vaccines.
2. The company’s GI portfolio includes vonoprazan, pantoprazole, lansoprazole and dexlansoprazole for gastric acid-related disorders like gastroesophageal reflux disease.
3. In March, the European Commission approved Takeda and TiGenix’s perianal fistulas drug Alofisel, the first time the European Commission approved an allogeneic stem cell therapy.
4. Takeda is Japan’s largest pharmaceutical company. It was founded in 1781 by Chobei Takeda I.
More articles on gastroenterology:
California hospital fined for failing to develop endoscopy cleaning program — 4 insights
Carolina Digestive Health Associates employee shared 100 patients’ data with fraud suspects
Dr. Eric Haas performs ‘J pouch’ surgery with da Vinci Xi: 3 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
